Inceptive Nucleics

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

AtomBioworks

This company develops artificial intelligence software for designing nucleic acids, including mRNA and aptamers, for biotechnology firms and medical research organisations.

Generate Biomedicine

This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

Creyon Bio

This company develops AI-designed oligonucleotide-based medicines and RNA-targeted therapies for pharmaceutical partners and patients with neuromuscular and immunological diseases.

Veritas In Silico

The company develops an AI-driven drug discovery platform for identifying mRNA-targeted medicines for pharmaceutical industry partners.

Serna Bio

This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.